Gadopentetate Dimeglumine Injection- Beijing Beilu Pharmaceutical Co., Ltd

Home>Product>Gadopentetate Dimeglumine Injection

Gadopentetate Dimeglumine Injection

FOB Price:Get Latest Price >
Min.Order:40000 Vial(s)
Payment Terms:T/T

Favorite

Beijing Beilu Pharmaceutical Co., Ltd

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

8/10

Product Information

Indication:MRI of human organs and tissues including central nervous system(brain and spinal cord), abdomen, chest, pelvic cavity, limbs ,etc.
Specification:469mg,10ml/12ml/15ml/20ml
Dosage Form:Injection
Route of Administration:Subcutaneous Injection
Shelf Life:3 years
Storage:Protected from light
Place of Origin:China
Qualification:Chinese GMP

Description

MRI CM The Gadopentetate Dimeglumine Injection developed by Beilu Pharm is the earliest approved MRI contrast agent in China, in 1992, it obtained the National Class II new drug certificate and the trail production approved issued by Ministry of Health. Its appearance breaks the foreign monopoly and fills the domestic blank. It is a classic MRI contrast agent taking the No.1 domestic market share and has been safely applied for more than 20 years, with good imaging enhancement and very few adverse reactions as reflected clinically.